Journal of Pharmacology and Experimental Therapeutics · 2019 · 51 citations · 27 references
Life SciencesImmunologyPharmacologyCell SignalingImmunoregulationInflammationAnti-inflammatory PharmacologyAtherosclerosis PharmacotherapyGlucagon-like Peptide-1 Receptor AgonistsInflammatory MediatorsInflammatory SignalingMacrophage BiologyAtherosclerosis Molecular MechanismsGlucagon-like Peptide 1 Receptor AgonismGlucagon-like Peptide 1 SignalingGlucagon-like Peptide-1 Receptor SignalingGlucagon-like PeptidesInnate Immune Cell FunctionMonocyte Chemoattractant Protein-1Proinflammatory Mediators
27
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice
Shiho Fujisaka, Isao Usui, Agussalim Bukhari et al. · Diabetes · 2009 · 715 citations · Full text